In Congo Outbreak, Ebola Vaccine Faces Cold-Chain Reality Tests
Supply Chain Brain
MAY 23, 2018
Because it is not yet licensed, the Merck & Co vaccine has been offered to Congo under a “compassionate use” protocol agreed by national and international health and ethics authorities. The hurdles illustrate how hard it can be to move from laboratory to real life, especially in remote communities with no functioning health systems.
Let's personalize your content